In vitro Reconstitution of Protein Translation of Thermus Thermophilus for Direct

Information

  • Research Project
  • 8496825
  • ApplicationId
    8496825
  • Core Project Number
    R44GM086930
  • Full Project Number
    5R44GM086930-03
  • Serial Number
    086930
  • FOA Number
    PA-11-096
  • Sub Project Id
  • Project Start Date
    2/1/2009 - 15 years ago
  • Project End Date
    6/30/2014 - 9 years ago
  • Program Officer Name
    MAAS, STEFAN
  • Budget Start Date
    7/1/2013 - 10 years ago
  • Budget End Date
    6/30/2014 - 9 years ago
  • Fiscal Year
    2013
  • Support Year
    03
  • Suffix
  • Award Notice Date
    6/20/2013 - 10 years ago

In vitro Reconstitution of Protein Translation of Thermus Thermophilus for Direct

DESCRIPTION (provided by applicant): Directed protein evolution is a powerful technology for protein engineering. It generally involves generating a library of protein variants and identifying those with desired properties by selection or screening. In terms of library complexity, in vitro selection methods are superior to cell-based selection methods by several orders of magnitude, allowing a much larger sequence space in proteins to be sampled. There is currently no effective in vitro method to select proteins with desired mutations that enhance their thermostability. Thermostable proteins can function at high temperatures, are generally robust and resistant to degradation under a variety of conditions, and therefore are valuable for a wide range of industrial and medical applications. This project intends to develop a technology for in vitro selection of protein thermostability. We plan to achieve this goal by (1) constructing a reconstituted in vitro protein synthesis system (thermo PURE system) using purified components from Thermus thermophilus, a bacterium that grows at an optimal temperature of 720C, and (2) applying such system for directed evolution of proteins with enhanced thermostability. We have successfully completed the first phase of the project (Phase I) and established an initial thermo PURE system that allowed in vitro synthesis of active full- length proteins at temperatures up to 600C. For the Phase II, we propose to commercialize the thermo PURE system by optimizing the system and testing more target proteins. We also propose to use the thermo PURE system in conjunction with in vitro selection technologies, such as in vitro compartmentalization and ribosome display, for directed evolution of thermostable proteins from their mesophilic origins. We plan to test several selection schemes of directed evolution for a variety of enzymes and proteins. If successful, this project would lead to the following unique and valuable commercial products: (1) a protein thermo synthesis kit; (2) a service for engineering proteins with enhanced thermostability; (3) thermostable nucleic acid enzymes as new reagents for research communities and thermostable single-chain antibodies for therapeutic applications.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    420705
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:420705\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NEW ENGLAND BIOLABS, INC.
  • Organization Department
  • Organization DUNS
    066605403
  • Organization City
    IPSWICH
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    019382723
  • Organization District
    UNITED STATES